Quick Answer
MYRIAD GENETICS INC reported Gross Profit of $576.60 million for fiscal year 2025.
MYRIAD GENETICS INC Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $576.60M | -1.5% |
| 2024 | $585.40M | +13.2% |
| 2023 | $517.00M | +8.5% |
| 2022 | $476.40M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $143.80M | -4.0% | -5.3% |
| June 30, 2025 | $151.80M | +3.2% | +13.1% |
| March 31, 2025 | $134.20M | -2.5% | -10.4% |
| September 30, 2024 | $149.80M | — | +1.8% |
| June 30, 2024 | $147.10M | — | +6.9% |
| March 31, 2024 | $137.60M | — | — |
- MYRIAD GENETICS INC showed a decrease of -1.5% in Gross Profit compared to the prior fiscal year.
- Over the 2022–2025 period, MYRIAD GENETICS INC’s gross profit has grown by 21.0% (from $476.40 million to $576.60 million).
- The most recent figure is from MYRIAD GENETICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: